Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according to new data presented at ...
May 17, 2021
0
5
(HealthDay)—The U.S. Food and Drug Administration is warning that strong magnets in some cellphones and smartwatches can interfere with pacemakers and other implanted medical devices.
May 14, 2021
0
1
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
A study of 2.4 million hospitalized cannabis users has found that those with an arrhythmia were 4.5 times more likely to die while in hospital than those without. The research is presented at EHRA 2021, an online scientific ...
Apr 23, 2021
0
13
On a recent day in his Denver Health emergency room, Dr. Eric Lavonas hit another tragic trifecta.
Apr 20, 2021
0
7
A Monash University study has uncovered for the first time a way to prevent and reverse damage caused by broken-heart syndrome, also known as Takotsubo cardiomyopathy.
Apr 20, 2021
0
358
While U.S. federal government experts probe potential risks of the Johnson & Johnson vaccine, what do you need to know if you have had the one-dose COVID shot or hope to get it?
Apr 16, 2021
0
11
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
Apr 12, 2021
0
3
Inflammation can be a visible part of how your body fights illness or injury. If you've ever sprained your ankle, you already know about it.
Apr 1, 2021
0
7
Makers of inhalers that contain the nasal decongestant propylhexedrine should make design changes to prevent misuse, the U.S. Food and Drug Administration says.
Mar 26, 2021
0
6
